Add to my selection

INREBIC (fédratinib)

Medicine - Posted on Oct 10 2024

Active substance (DCI)

fédratinib

history (2)

9/25/24

INREBIC (fedratinib) - Disease-related splenomegaly

Summary of opinion. Favourable opinion for maintenance of reimbursement in “the treatment of disease-related splenomegaly or...

CAV :
54321

icône flèche
12/15/21

INREBIC (fédratinib)

Key points Favourable opinion for reimbursement in the treatment of disease-related splenomegaly or symptoms in adult patien...

CAV :
54321

icône flèche

Technical information

ATC code

L01EJ02

Manufacturer

BRISTOL-MYERS SQUIBB

Presentation

INREBIC 100 mg, gélule
flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 120 gélule(s) (CIP : 34009 302 326 2 0)

All our publications

Blood and lymphatic diseases - miscellaneous

Bone marrow diseases